Deanna J. Brackman

Venetoclax Plus Gilteritinib for <i>FLT3</i>-Mutated Relapsed/Refractory Acute Myeloid Leukemia

Naval Daver, Alexander E. Perl, Joseph Maly et al. · Journal of Clinical Oncology · 2022 · 187 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

A genome-wide association analysis reveals new pathogenic pathways in gout

Tanya J. Major, Riku Takei, Hirotaka Matsuo et al. · Nature Genetics · 2024 · 82 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

Efficient Delivery of the Toll-like Receptor Agonists Polyinosinic:Polycytidylic Acid and CpG to Macrophages by Acetalated Dextran Microparticles

Kevin J. Peine, Eric M. Bachelder, Zachary VanGundy et al. · Molecular Pharmaceutics · 2013 · 57 citations

Pharmacy, Immunology, Pharmaceutics +16

A conserved role of the insulin-like signaling pathway in diet-dependent uric acid pathologies in Drosophila melanogaster

Sven Lang, Tyler Hilsabeck, Kenneth A. Wilson et al. · PLoS Genetics · 2019 · 56 citations · Full text

Life Sciences, Biology, Genetics +17

Venetoclax exposure‐efficacy and exposure‐safety relationships in patients with treatment‐naïve acute myeloid leukemia who are ineligible for intensive chemotherapy

Deanna J. Brackman, Doerthe Eckert, Rajeev Menon et al. · Hematological Oncology · 2022 · 48 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14